Literature DB >> 25938746

High-throughput genotyping of high-risk Human Papillomavirus by MALDI-TOF Mass Spectrometry-based method.

Monica Cricca1, Elena Marasco2, Federica Alessandrini1, Chiara Fazio2, Anna Prossomariti2, Claudia Savini1, Simona Venturoli3, Pasquale Chieco2, Sabrina De Carolis1, Massimiliano Bonafè4, Maria Carla Re1, Paolo Garagnani2, Vilma Mantovani2.   

Abstract

A high-throughput matrix-assisted laser desorption ionisation-time of flight (MALDI-TOF) mass spectrometry (MS)-based method was here developed to genotype 16 high-risk human papillomavirus (HPV) types in cervical cytology specimens. This method was compared to a commercial kit, the Inno-LiPA HPV genotyping assay, which detects a broad spectrum of HPV types. HPV DNA was assessed by the two methods in a total of 325 cervical cytology specimens collected in PreservCyt® solution. The overall agreement was almost perfect (Cohen's k=0.86) in term of positive and negative cases. Indeed, HPV types 16, 35, 56 and 66 showed the highest agreement values (>0.80). The highest agreement values (K >0.80) were found for all 16 HPV types in single infections, but only for HPV 16, 35, 45 and 56 in multiple infections. In conclusion, the high-throughput MS-based method developed here is well-suited for broad spectrum HPV genotyping in large-scale epidemiological studies.

Entities:  

Keywords:  Cervical cancer; Genotyping; HPV; High-throughput; Inno-LiPA; MALDI-TOF MS

Mesh:

Year:  2015        PMID: 25938746

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  8 in total

Review 1.  Human Papillomavirus Laboratory Testing: the Changing Paradigm.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

2.  Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) proteomic profiling of cerebrospinal fluid in the diagnosis of enteroviral meningitis: a proof-of-principle study.

Authors:  Ignacio Torres; Estela Giménez; Víctor Vinuesa; Tania Pascual; Juan Miguel Moya; Juan Alberola; Ana Martínez-Sapiña; David Navarro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-27       Impact factor: 3.267

3.  Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry.

Authors:  Sarah E Ashley; Braydon A Meyer; Justine A Ellis; David J Martino
Journal:  J Vis Exp       Date:  2018-06-21       Impact factor: 1.355

Review 4.  Candidate biomarkers in the cervical vaginal fluid for the (self-)diagnosis of cervical precancer.

Authors:  Xaveer Van Ostade; Martin Dom; Wiebren Tjalma; Geert Van Raemdonck
Journal:  Arch Gynecol Obstet       Date:  2017-11-15       Impact factor: 2.344

5.  HPV DNA Associates With Breast Cancer Malignancy and It Is Transferred to Breast Cancer Stromal Cells by Extracellular Vesicles.

Authors:  Sabrina De Carolis; Gianluca Storci; Claudio Ceccarelli; Claudia Savini; Lara Gallucci; Pasquale Sansone; Donatella Santini; Renato Seracchioli; Mario Taffurelli; Francesco Fabbri; Fabrizio Romani; Gaetano Compagnone; Cristina Giuliani; Paolo Garagnani; Massimiliano Bonafè; Monica Cricca
Journal:  Front Oncol       Date:  2019-09-16       Impact factor: 6.244

6.  Development of high-throughput genotyping method of all 18 HR HPV based on the MALDI-TOF MS platform and compared with the Roche Cobas 4800 HPV assay using clinical specimens.

Authors:  Xushan Cai; Qinghua Guan; Yu Huan; Ziyu Liu; Jiehua Qi; Shichao Ge
Journal:  BMC Cancer       Date:  2019-08-22       Impact factor: 4.430

7.  Prevalence and correlation of human papillomavirus genotypes with clinical factors in cervical samples from Mexican women.

Authors:  Fabiola Hernández-Rosas; Erika Orozco-Hernández; Liliana Maza-Sánchez; Pamela Citlalli Salgado-García; Enrique Navarro-Vidal; Mercedes Piedad de León-Bautista
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-22

8.  Consistency evaluation of Liferiver, Yaneng, Darui, and the Cobas 4800 test for high-risk human papillomavirus screening.

Authors:  Mengmeng Wang; Xiang Ji; Xiaowen Dou; Huamei Tang; Lijuan Kan; Wei Wu; Dayang Chen; Zengyan Zong; Dan Xiong; Xiuming Zhang
Journal:  J Clin Lab Anal       Date:  2020-08-19       Impact factor: 3.124

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.